Search

  • Sort by

  • Category

  • Post Type

  • Reset

October 7, 2024: DEA warning – Dozens of fake online pharmacies sold millions of fake pills to customers in all 50 states

October 7, 2024
Posted in ,

An indictment by the Department of Justice against 18 individuals who allegedly sold counterfeit pills via dozens of fake pharmacy websites to residents in all 50 states prompts warnings from two additional federal agencies.

Read More

What it means that the shortage of weight loss drugs is almost over

October 3, 2024
Posted in

Drug shortages attract patient risk in many forms. Since first seeing compounded semaglutide for sale on Etsy in early 2023, the Partnership for Safe Medicines has recognized the unique threats that counterfeit and substandard versions of FDA-approved diabetes and obesity injectable medicines pose to consumer safety. Because unprecedented demand has outweighed the FDA-approved supply, PSM has used its platform as…

Read More

September 30, 2024: 27 individuals indicted in Puerto Rico over wholesale distribution of misbranded and diverted medicine

September 30, 2024
Posted in ,

Twenty-seven people in Puerto Rico indicted in misbranded and diverted drug case, CBP seized counterfeit and misbranded drugs in two states, and fake arthritis and cancer medications seized in India.

Read More

PSM Compounded Weight Loss Drugs Poll

September 26, 2024
Posted in ,

PSM commissioned a survey about compounded diabetes and weight loss injectable drugs. 1,000 likely voters across political affiliations were crystal clear — they are worried about safety and the current lack of oversight. See the full results.

Read More

September 23, 2024: Administrative complaint filed alleging insulin price inflation by pharmacy benefit managers

September 23, 2024
Posted in ,

The Federal Trade Commission issued an administrative complaint against the three largest pharmacy benefit managers, alleging that the companies used their market power to inflate the cost of insulin for U.S. patients.

Read More

FDA Alert: Herbal Supplement Recalled for Containing Prescription Steroids and OTC Antihistamines

September 23, 2024
Posted in ,

If used chronically at the recommended dose, dexamethasone could cause severe and serious adverse events such as adrenal suppression (a disorder in which the adrenal glands do not produce enough hormones), central nervous system and psychiatric/behavioral effects, weight gain, gastrointestinal effects, elevated blood glucose, increased infection risks, neuromuscular and skeletal side effects, ocular effects, cardiovascular effects, dermatologic effects endocrine and metabolic issues, among other adverse events not mentioned.

Read More

September 16, 2024: An ongoing lawsuit suggests peril for pharmacy-to-pharmacy market place users

September 16, 2024
Posted in

Rxeed’s suit of CVS Caremark alleges predatory practices against independent pharmacies. Walgreens joins up with NABP’s Pulse. Stories about medicine safety in the U.S. and around the world.

Read More

Government’s Sentencing Memo, USA v Lorik Papyan

September 10, 2024
Posted in , , ,

United States District Court Northern District of California USA v  Lorik Papyan Government Sentencing Memo Filed June 11, 2024 Read the document. 

Read More

Government’s Sentencing Memo, USA v Stephen Silverman

September 10, 2024
Posted in , , , ,

United States District Court Northern District of California USA v  Stephen Silverman Government Sentencing Memo Filed February 27, 2024 Read the document. 

Read More

Criminal Complaint, USA v Hakob Kojoyan

September 10, 2024
Posted in , ,

United States District Court Northern District of California USA v  Hakob Kojoyan Criminal Complaint Filed April 30, 2018 Read the document. 

Read More